Recruiting

Internet-based Support for Adjustment to Prostate Cancer

The study aims to study the efficacy of internet-based cognitive behavior therapy (ICBT) in reducing subjective distress and comorbid psychiatric symptoms in men diagnosed with prostate cancer. Participants who have been diagnosed with prostate cancer and are currently not undergoing or scheduled to undergo medical treatment will be recruited. Once recruited, they will be randomized to receive either a tailored, eight-week long ICBT intervention or an attention control group. Both group receive weekly support by a…

I'm interested View official listing
ClinicalTrials.gov IDNCT06766526
PhaseNA
Enrollment180
SponsorLinkoeping University
Age18 Years and older
SexMALE
I'm interested View official listing

Conditions studied

Psychological Distress, Depression - Major Depressive Disorder, Insomnia, Anxiety, Prostate Cancer

About this study

The study aims to study the efficacy of internet-based cognitive behavior therapy (ICBT) in reducing subjective distress and comorbid psychiatric symptoms in men diagnosed with prostate cancer. Participants who have been diagnosed with prostate cancer and are currently not undergoing or scheduled to undergo medical treatment will be recruited. Once recruited, they will be randomized to receive either a tailored, eight-week long ICBT intervention or an attention control group. Both group receive weekly support by a trained therapist.

Interventions

Primary outcomes

Eligibility information

Inclusion Criteria: * Subjectively reported psychological symptoms and problems that have come about after a prostate cancer diagnosis. * A sum score above 19 on the primary outcome measure (Kessler-10). * An age of 18 or older. * Ability to speak, read, and write Swedish. * Access to a computer/laptop/tablet/smartphone and internet access. * Sufficient computer profiency to be able to use the treatment platform. Exclusion Criteria: * Planned medical treatment or planned change in medication related to the prostate cancer during the treatment period. * Recently finished (within the past six months) medical treatment for prostate cancer. * Severe psychiatric or somatic conditions that impedes participation in the study. * Ongoing substance use problems. * Acute suicidality. * Other ongoing psychological treatment. * Psychopharmaceutic treatment that has been changed within the past month or with planned changes during the treatment phase.

Study locations

Before you participate: Varda Clinical is an independent discovery tool, not the study sponsor or a medical provider. Eligibility can only be determined by the official study team. Discuss potential risks and benefits with a qualified healthcare professional.

Source: ClinicalTrials.gov. Record last refreshed by Varda Clinical: 2026-11-19.